Aike Ho is listed as a director on 5 SEC Form D filings by 2 issuers between Feb 2021 and Sep 2025: Brightside Health, Inc. (Oakland, CA — other technology — 2021; $46M reported sold to 14 investors) and Conceivable Life Sciences Inc. (New York, NY — other health care — 2024–2025; $30.5M reported sold to 20 investors).
What this means 2 separate companies raised money with this person listed as director, over about 4 years. Across those companies the filings report $76.5M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Aike Ho and found 5 differences: Form D filed 41 days after the first sale; Form D filed 25 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.